drugset / Trial / NCT01764867
Algorithm Guided Treatment Strategies for Major Depressive Disorder
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare treatment outcomes between measurement based Algorithm Guided Treatment and Treatment As Usual strategies in a Chinese population with major depressive disorder.
Timeline
- Start
- 2012-06
- Primary completion
- 2014-10
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Escitalopram | Small molecule | 10 mg | — |
| Comparator | Escitalopram | Small molecule | 20 mg | — |
| Comparator | Mirtazapine | Other / unclassified | 30 mg | — |
| Comparator | Mirtazapine | Other / unclassified | 45 mg | — |
| Comparator | Bupropion | Small molecule | — | — |
| Comparator | Citalopram | Small molecule | — | — |
| Comparator | Duloxetine | Small molecule | — | — |
| Comparator | Fluoxetine | Small molecule | — | — |
| Comparator | Fluvoxamine | Unknown | — | — |
| Comparator | Paroxetine | Small molecule | — | — |
| Comparator | Sertraline | Small molecule | — | — |
| Comparator | Trazodone | Small molecule | — | — |
| Comparator | Venlafaxine | Small molecule | — | — |